JP2024517861A5 - - Google Patents

Info

Publication number
JP2024517861A5
JP2024517861A5 JP2023568277A JP2023568277A JP2024517861A5 JP 2024517861 A5 JP2024517861 A5 JP 2024517861A5 JP 2023568277 A JP2023568277 A JP 2023568277A JP 2023568277 A JP2023568277 A JP 2023568277A JP 2024517861 A5 JP2024517861 A5 JP 2024517861A5
Authority
JP
Japan
Prior art keywords
stereoisomers
stereoisomer
pharmaceutically acceptable
solvate
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023568277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517861A (ja
JP7871296B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2022/051166 external-priority patent/WO2022234298A1/en
Publication of JP2024517861A publication Critical patent/JP2024517861A/ja
Publication of JP2024517861A5 publication Critical patent/JP2024517861A5/ja
Application granted granted Critical
Publication of JP7871296B2 publication Critical patent/JP7871296B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023568277A 2021-05-06 2022-05-06 PKC-θモジュレーター Active JP7871296B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB202106485 2021-05-06
GB2106485.2 2021-05-06
PCT/GB2022/051166 WO2022234298A1 (en) 2021-05-06 2022-05-06 Pkc-theta modulators

Publications (3)

Publication Number Publication Date
JP2024517861A JP2024517861A (ja) 2024-04-23
JP2024517861A5 true JP2024517861A5 (cg-RX-API-DMAC7.html) 2025-12-01
JP7871296B2 JP7871296B2 (ja) 2026-06-08

Family

ID=82100190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568277A Active JP7871296B2 (ja) 2021-05-06 2022-05-06 PKC-θモジュレーター

Country Status (14)

Country Link
US (2) US20240262821A1 (cg-RX-API-DMAC7.html)
EP (1) EP4333982A1 (cg-RX-API-DMAC7.html)
JP (1) JP7871296B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240024062A (cg-RX-API-DMAC7.html)
CN (1) CN117355522A (cg-RX-API-DMAC7.html)
AU (1) AU2022269883A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023022706A2 (cg-RX-API-DMAC7.html)
CA (1) CA3213703A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023003246A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023014939A2 (cg-RX-API-DMAC7.html)
IL (1) IL307665A (cg-RX-API-DMAC7.html)
MX (1) MX2023013013A (cg-RX-API-DMAC7.html)
PE (1) PE20240070A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022234298A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3214088A1 (en) * 2021-05-06 2022-11-10 Peter Ray Pkc-theta modulators
WO2025235367A1 (en) * 2024-05-06 2025-11-13 D. E. Shaw Research, Llc Azaindolinone compounds as kca3.1 potassium channel blockers
WO2025255298A1 (en) * 2024-06-06 2025-12-11 Bristol-Myers Squibb Company Pkc-theta inhibitors, compositions, and methods of use
WO2025255292A1 (en) * 2024-06-06 2025-12-11 Bristol-Myers Squibb Company Pkc-theta inhibitors, compositions, and methods of use
WO2025255288A1 (en) * 2024-06-06 2025-12-11 Bristol-Myers Squibb Company Pkc-theta inhibitors, compositions, and methods of use
KR20260031910A (ko) * 2024-08-30 2026-03-09 한국과학기술연구원 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 5,7-다이하이드로-6H-피롤로[2,3-d]피리미딘-6-온 유도체 및 이들의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173635B2 (en) * 2007-11-02 2012-05-08 Vertex Pharmaceuticals Incorporated Kinase inhibitors
CA2713864A1 (en) * 2008-02-04 2009-08-13 Cytokinetics, Incorporated Certain chemical entities, compositions and methods
GB0920382D0 (en) 2009-11-20 2010-01-06 Univ Dundee Design of molecules
AU2010352577A1 (en) * 2010-05-05 2012-01-19 Vertex Pharmaceuticals Incorporated 4 substituted pyrazolopyrimidines useful as PKC-theta inhibitors
RU2016129380A (ru) 2013-12-20 2018-01-25 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
US9624170B2 (en) * 2013-12-26 2017-04-18 Takeda Pharmaceutical Company Limited 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
AU2017312970B2 (en) * 2016-08-16 2021-08-12 Merck Patent Gmbh 2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof
EP3976612A4 (en) * 2019-05-28 2023-04-26 Mankind Pharma Ltd NEW COMPOUNDS FOR INHIBITION OF JANUS KINASE 1
CN112480116B (zh) * 2019-09-11 2024-03-29 南京正大天晴制药有限公司 Pkb抑制剂
CA3214088A1 (en) * 2021-05-06 2022-11-10 Peter Ray Pkc-theta modulators

Similar Documents

Publication Publication Date Title
JP2024518447A5 (cg-RX-API-DMAC7.html)
US9505737B2 (en) Treprostinil derivative compounds and methods of using same
RU2008144584A (ru) 4,5-дигидро-[1,2,4]триазоло[4,3-f]птеридины в качестве ингибиторов протеинкиназы plk1 для лечения пролиферативных заболеваний
JP2025071130A5 (cg-RX-API-DMAC7.html)
RU2430923C2 (ru) Тиазолилдигидрохиназолины
RU2012117398A (ru) Бензоксазепиновые ингибиторы pi3 и способы применения
JP2023550122A5 (cg-RX-API-DMAC7.html)
JP2021514373A5 (cg-RX-API-DMAC7.html)
RU2005110061A (ru) Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло(2,2,1)гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина
JP2021523887A (ja) XIIa因子インヒビター
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2005538099A5 (cg-RX-API-DMAC7.html)
JP2006511552A5 (cg-RX-API-DMAC7.html)
JP2004517843A5 (cg-RX-API-DMAC7.html)
JP2021102643A5 (cg-RX-API-DMAC7.html)
JP2019502686A5 (cg-RX-API-DMAC7.html)
WO2021201201A1 (ja) 新型コロナウイルス感染症(covid-19)の予防または治療剤および医薬組成物
WO2015002755A2 (en) Compounds for the treatment of malaria
RU2002105518A (ru) Гетероциклические соединения, ингибирующие ангиогенез
RU2015106013A (ru) Соединения пиразолкарбоксамида, композиции и способы применения
AU2011271480B2 (en) Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
JP2023522693A5 (cg-RX-API-DMAC7.html)
RU2011121511A (ru) Гетероциклические антивирусные производные арилпиридона
CA2345284A1 (en) Blood pressure stabilization during hemodialysis
EA200970444A1 (ru) Способ введения противоопухолевого соединения